Mark Adamchak - 02 Feb 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Principal Accounting Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
02 Feb 2026
Net transactions value
$0
Form type
4
Filing time
04 Feb 2026, 16:19:48 UTC
Previous filing
03 Jun 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Adamchak Mark Principal Accounting Officer C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO /s/ Jonathan V. Dixon, Attorney-in-Fact 04 Feb 2026 0002036536

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +10,890 $0.000000 10,890 02 Feb 2026 Common Stock 10,890 $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option vest on the one-year anniversary of the grant date.